Claims
- 1. A process for enzymatically converting a substrate into a product comprising:
- a) electrochemically reducing a cytoplasmic hydrogenase enzyme obtained from Rhodococcus sp., which were previously identified as Nocardia opaca DSM 427, with an electrode;
- b) transferring electrons from said cytoplasmic hydrogenase enzyme to a nicotinamide cofactor in the absence of methyl viologen;
- c) catalytically converting a substrate into a product with an enzyme and said nicotinamide cofactor; and
- d) regenerating said nicotinamide cofactor with said cytoplasmic hydrogenase.
- 2. The process of claim 1, wherein said electrode comprises a precious metal.
- 3. The process of claim 2, wherein said electrode comprises platinum.
- 4. The process of claim 1, wherein an electrolysis potential of between -0.5 to -0.9 volts is used.
- 5. The process of claim 1, wherein an electrolysis potential of between -0.65 to -0.75 volts is used.
- 6. The process of claim 2, wherein said process is conducted at a pH of between 5 to 10.
- 7. The process of claim 1, wherein an electrolysis potential of between -0.5 to -0.75 volts is used.
- 8. The process of claim 1, wherein NADH is added to the medium with the co-factor NAD.sup.+.
- 9. The process of claim 1, wherein there is a direct electrode-cytoplasmic hydrogenase enzyme electron transfer.
- 10. A process for enzymatically converting a substrate into a product comprising:
- a) electrochemically reducing a cytoplasmic hydrogenase enzyme obtained from Alcaligenes eutrophus with an electrode;
- b) transferring electrons from said cytoplasmic hydrogenase enzyme to a nicotinamide cofactor in the absence of methyl viologen;
- c) catalytically converting a substrate into a product with an enzyme and said nicotinamide cofactor; and
- d) regenerating said nicotinamide cofactor with said cytoplasmic hydrogenase.
- 11. The process of claim 10, wherein said electrode comprises a precious metal.
- 12. The process of claim 11, wherein said electrode comprises platinum.
- 13. The process of claim 10, wherein an electrolysis potential of between -0.5 to -0.9 volts is used.
- 14. The process of claim 10, wherein an electrolysis potential of between -0.65 to -0.75 volts is used.
- 15. The process of claim 11, wherein said process is conducted at a pH of between 5 to 10.
- 16. The process of claim 10, wherein an electrolysis potential of between -0.5 to -0.75 volts is used.
- 17. The process of claim 10, wherein NADH is added to the medium with the co-factor NAD.sup.+.
- 18. The process of claim 10, wherein there is a direct electrode-cytoplasmic hydrogenase enzyme electron transfer.
- 19. The process of claim 10 wherein said cytoplasmic hydrogenase enzyme is obtained from Alcaligenes eutrophus ATCC 17699.
Priority Claims (1)
Number |
Date |
Country |
Kind |
88 11933 |
Sep 1988 |
FRX |
|
Parent Case Info
This application is a Continuation-in-part application of U.S. Ser. No. 07/919,379 filed on Jul. 29, 1992, now abandoned which is a Continuation application of U.S. Ser. No. 07/404,455 filed on Sep. 8, 1989, now abandoned. The entire contents of U.S. Ser. No. 07/919,379 are hereby incorporated by reference.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
4318784 |
Higgins et al. |
Mar 1982 |
|
4464235 |
Simon et al. |
Aug 1984 |
|
Non-Patent Literature Citations (4)
Entry |
Schneider et al, Eur. J. Bio Chem 142: 75-84 (1984). |
Egerer et al., BBA 703: 149-157 (1982). |
Bader et al., J. Biotechnol. 1: 95-109 (1984). |
ATCC Catalogue of Bacteria and Phages p. 273 (1992). |
Continuations (1)
|
Number |
Date |
Country |
Parent |
404455 |
Sep 1989 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
919379 |
Jul 1992 |
|